✦ LIBER ✦

The significance of fetal maxillary length in the first trimester screening for trisomy 21

✍ Scribed by Naim Unsal; Mustafa Ozat; Mine Kanat-Pektas; Tayfun Gungor; Nuri Danisman

Publisher: Springer
Year: 2010
Tongue: English
Weight: 379 KB
Volume: 283
Category: Article
ISSN: 0003-9128
DOI: 10.1007/s00404-010-1527-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ultrasound screening for fetal abnormali

Ultrasound screening for fetal abnormalities in the first trimester

✍ Lyn S. Chitty; Pranav P. Pandya 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB 👁 3 views

There has been an increase in the use of fetal ultrasound in the first trimester over the last few years. This paper will review the published literature on first trimester ultrasound screening programmes for both aneuploidy and fetal structural abnormalities. 1997 by John Wiley & Sons, Ltd.

Maternal serum screening for trisomy 18

Maternal serum screening for trisomy 18 in the first trimester of pregnancy

✍ Roberto Biagiotti; Ettore Cariati; Laura Brizzi; Gino Cappelli; Alberino D'Agata 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB 👁 3 views

The aim of this study was to evaluate the feasibility of first-trimester biochemical screening for trisomy 18, by using pregnancy-associated plasma protein A (PAPP-A) and free beta human chorionic gonadotropin (hCG) in combination with maternal age. Maternal serum levels of PAPP-A and free beta-hCG

Screening for trisomy 21 in twin pregnan

Screening for trisomy 21 in twin pregnancies in the first trimester using free β-hCG and PAPP-A, combined with fetal nuchal translucency thickness

✍ Kevin Spencer 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB 👁 1 views

In the ®rst trimester of pregnancy the biochemical markers free b-hCG and pregnancy associated plasma protein-A (PAPP-A) are used for the prenatal screening of trisomy 21, either alone or in combination with nuchal translucency (NT) thickness. In this study, I have analysed the distribution of these

Critical reappraisal of the utility of s

Critical reappraisal of the utility of sonographic fetal femur length in the prediction of trisomy 21

✍ Patrizia Vergani; Anna Locatelli; Maria Giovanna Piccoli; Eloisa Mariani; Nicola 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 2 views

Measurement of femur length (FL) has been advocated as part of a genetic sonogram for the prediction of Down syndrome (DS). However its predictive ability has been inconsistent. We have studied the diagnostic value of this sonographic parameter in a prospective cohort of women with singleton gestati

Women's opinions and the implications of

Women's opinions and the implications of first- versus second-trimester screening for fetal Down's syndrome

✍ L. H. Kornman; M. J. M. Wortelboer; J. R. Beekhuis; L. P. Morssink; A. Mantingh 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 3 views

Two groups of pregnant women were questioned regarding their opinions on serum screening for Down's syndrome in the first trimester of pregnancy. One group comprised 83 women attending our antenatal clinic who were questioned at the time of the existing second-trimester screening test. Seventy-six p

Is maternal serum total hCG a marker of

Is maternal serum total hCG a marker of trisomy 21 in the first trimester of pregnancy?

✍ Kevin Spencer; Esther Berry; Jennifer A. Crossley; David A. Aitken; Kypros H. Ni 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 3 views

In a study of 130 ®rst trimester cases of trisomy 21 and 959 controls we have shown that the median MoM for alpha-fetoprotein (AFP) is lower (0.82) and that for total human chorionic gonadotrophin (hCG) is higher (1.31) than in the control group. For AFP 15.3% of cases were below the 5th centile and